Nagler, A <br/><br/>
Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Mar 2000 
 - 641-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0270-9139 
<br/><br/><label>Standard No.: </label>10.1002/hep.510310314  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Autoimmunity<br/>Cell Transplantation<br/>Chronic Disease<br/>Collagen--genetics<br/>Female<br/>Graft vs Host Disease--blood<br/>In Situ Hybridization<br/>Interferon-gamma--blood<br/>Interleukin-10--blood<br/>Interleukin-2--blood<br/>Liver Diseases--complications<br/>Mice<br/>Mice, Inbred BALB C<br/>Proteins--administration & dosage<br/>Spleen--cytology<br/>Tumor Necrosis Factor-alpha--analysis